Boiano James M, Steege Andrea L, Sweeney Marie H
a Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health Centers for Disease Control and Prevention , Cincinnati , Ohio.
J Occup Environ Hyg. 2015;12(9):588-602. doi: 10.1080/15459624.2015.1029610.
Precautionary guidelines detailing standards of practice and equipment to eliminate or minimize exposure to antineoplastic drugs during handling activities have been available for nearly three decades. To evaluate practices for compounding antineoplastic drugs, the NIOSH Health and Safety Practices Survey of Healthcare Workers was conducted among members of professional practice organizations representing primarily oncology nurses, pharmacists, and pharmacy technicians. This national survey is the first in over 20 years to examine self-reported use of engineering, administrative, and work practice controls and PPE by pharmacy practitioners for minimizing exposure to antineoplastic drugs. The survey was completed by 241 nurses and 183 pharmacy practitioners who compounded antineoplastic drugs in the seven days prior to the survey. They reported: not always wearing two pairs of chemotherapy gloves (85%, 47%, respectively) or even a single pair (8%, 10%); not always using closed system drug-transfer devices (75%, 53%); not always wearing recommended gown (38%, 20%); I.V. lines sometimes/always primed with antineoplastic drug (19%, 30%); and not always using either a biological safety cabinet or isolator (9%, 15%). They also reported lack of: hazard awareness training (9%, 13%); safe handling procedures (20%, 11%); and medical surveillance programs (61%, 45%). Both employers and healthcare workers share responsibility for adhering to precautionary guidelines and other best practices. Employers can ensure that: workers are trained regularly; facility safe-handling procedures reflecting national guidelines are in place and support for their implementation is understood; engineering controls and PPE are available and workers know how to use them; and medical surveillance, exposure monitoring, and other administrative controls are in place. Workers can seek out training, understand and follow facility procedures, be role models for junior staff, ask questions, and report any safety concerns.
近三十年来,一直存在详细说明操作规范和设备标准的预防指南,以消除或尽量减少在处理活动中接触抗肿瘤药物。为评估配制抗肿瘤药物的操作情况,美国国家职业安全与健康研究所(NIOSH)对主要代表肿瘤学护士、药剂师和药房技术员的专业实践组织成员进行了医护人员健康与安全实践调查。这项全国性调查是20多年来首次对药剂师在自我报告中使用工程控制、行政控制和工作实践控制以及个人防护装备(PPE)以尽量减少接触抗肿瘤药物的情况进行研究。在调查前七天内配制过抗肿瘤药物的241名护士和183名药剂师完成了该调查。他们报告称:并非总是戴两副化疗手套(分别为85%、47%),甚至连一副都不总是戴(分别为8%、10%);并非总是使用密闭式药物转移装置(分别为75%、53%);并非总是穿推荐的防护服(分别为38%、20%);静脉输液管路有时/总是用抗肿瘤药物预充(分别为19%、30%);并非总是使用生物安全柜或隔离器(分别为9%、15%)。他们还报告称缺乏:危害意识培训(分别为9%、13%);安全操作程序(分别为20%、11%);以及医疗监测计划(分别为61%、45%)。雇主和医护人员都有责任遵守预防指南和其他最佳实践。雇主可以确保:定期对工人进行培训;制定符合国家指南的设施安全操作程序,并确保对其实施的支持得到理解;提供工程控制措施和个人防护装备,且工人知道如何使用;实施医疗监测、接触监测和其他行政控制措施。工人可以寻求培训,理解并遵守设施程序,为初级员工树立榜样,提出问题,并报告任何安全问题。